A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer

NCT01050985 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Temsirolimus and capecitabine

Sponsor

Georgetown University

Collaborators

[object Object]